Lates News

The biotechnology company Dyadic International dropped by 2.3%. The company announced that it expects to achieve $500,000 in milestone revenue as it transitions to a commercial biotechnology enterprise. The company recently completed a $5.3 million equity financing and is currently focusing on developing scalable protein production technology.